Thermo Fisher ScientificTMO
About: Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).
Employees: 122,000
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
5% more capital invested
Capital invested by funds: $194B [Q2] → $204B (+$10.4B) [Q3]
3% more funds holding in top 10
Funds holding in top 10: 111 [Q2] → 114 (+3) [Q3]
4% more repeat investments, than reductions
Existing positions increased: 992 | Existing positions reduced: 958
1% less funds holding
Funds holding: 2,493 [Q2] → 2,469 (-24) [Q3]
4.95% less ownership
Funds ownership: 91.92% [Q2] → 86.97% (-4.95%) [Q3]
13% less call options, than puts
Call options by funds: $1.59B | Put options by funds: $1.82B
13% less first-time investments, than exits
New positions opened: 164 | Existing positions closed: 188
Research analyst outlook
17 Wall Street Analysts provided 1 year price targets over the past 3 months
17 analyst ratings
Bernstein Eve Burstein 100% 1-year accuracy 1 / 1 met price target | 21%upside $620 | Market Perform Maintained | 24 Oct 2024 |
RBC Capital Conor McNamara 34% 1-year accuracy 14 / 41 met price target | 40%upside $718 | Outperform Maintained | 24 Oct 2024 |
Stifel Daniel Arias 17% 1-year accuracy 3 / 18 met price target | 30%upside $665 | Buy Maintained | 24 Oct 2024 |
Evercore ISI Group Vijay Kumar 65% 1-year accuracy 30 / 46 met price target | 21%upside $620 | Outperform Maintained | 24 Oct 2024 |
Wells Fargo Brandon Couillard 24% 1-year accuracy 4 / 17 met price target | 29%upside $660 | Overweight Maintained | 24 Oct 2024 |
Financial journalist opinion
Based on 18 articles about TMO published over the past 30 days
